Literature DB >> 25900980

Regulation of thrombosis and vascular function by protein methionine oxidation.

Sean X Gu1, Jeff W Stevens1, Steven R Lentz1.   

Abstract

Redox biology is fundamental to both normal cellular homeostasis and pathological states associated with excessive oxidative stress. Reactive oxygen species function not only as signaling molecules but also as redox regulators of protein function. In the vascular system, redox reactions help regulate key physiologic responses such as cell adhesion, vasoconstriction, platelet aggregation, angiogenesis, inflammatory gene expression, and apoptosis. During pathologic states, altered redox balance can cause vascular cell dysfunction and affect the equilibrium between procoagulant and anticoagulant systems, contributing to thrombotic vascular disease. This review focuses on the emerging role of a specific reversible redox reaction, protein methionine oxidation, in vascular disease and thrombosis. A growing number of cardiovascular and hemostatic proteins are recognized to undergo reversible methionine oxidation, in which methionine residues are posttranslationally oxidized to methionine sulfoxide. Protein methionine oxidation can be reversed by the action of stereospecific enzymes known as methionine sulfoxide reductases. Calcium/calmodulin-dependent protein kinase II is a prototypical methionine redox sensor that responds to changes in the intracellular redox state via reversible oxidation of tandem methionine residues in its regulatory domain. Several other proteins with oxidation-sensitive methionine residues, including apolipoprotein A-I, thrombomodulin, and von Willebrand factor, may contribute to vascular disease and thrombosis.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25900980      PMCID: PMC4473114          DOI: 10.1182/blood-2015-01-544676

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  104 in total

Review 1.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

2.  Deficiency of methionine sulfoxide reductase A causes cellular dysfunction and mitochondrial damage in cardiac myocytes under physical and oxidative stresses.

Authors:  Changlong Nan; Yuejin Li; Pierre-Yves Jean-Charles; Guozhen Chen; Alexander Kreymerman; Howard Prentice; Herbert Weissbach; Xupei Huang
Journal:  Biochem Biophys Res Commun       Date:  2010-10-28       Impact factor: 3.575

Review 3.  Cytoprotective protein C pathways and implications for stroke and neurological disorders.

Authors:  Berislav V Zlokovic; John H Griffin
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

4.  Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS-13.

Authors:  S Lancellotti; V De Filippis; N Pozzi; L Oggianu; S Rutella; G L Scaglione; F Maset; F Peyvandi; P M Mannucci; R De Cristofaro
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

Review 5.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

6.  Myristoylated methionine sulfoxide reductase A protects the heart from ischemia-reperfusion injury.

Authors:  Hang Zhao; Junhui Sun; Anne M Deschamps; Geumsoo Kim; Chengyu Liu; Elizabeth Murphy; Rodney L Levine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-12       Impact factor: 4.733

7.  Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue.

Authors:  Thijs van Iersel; Heimo Stroissnig; Peter Giesen; Johan Wemer; Karin Wilhelm-Ogunbiyi
Journal:  Thromb Haemost       Date:  2010-11-23       Impact factor: 5.249

8.  Redox proteomics of protein-bound methionine oxidation.

Authors:  Bart Ghesquière; Veronique Jonckheere; Niklaas Colaert; Joost Van Durme; Evy Timmerman; Marc Goethals; Joost Schymkowitz; Frederic Rousseau; Joël Vandekerckhove; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2011-03-15       Impact factor: 5.911

9.  Oxidized CaMKII causes cardiac sinus node dysfunction in mice.

Authors:  Paari Dominic Swaminathan; Anil Purohit; Siddarth Soni; Niels Voigt; Madhu V Singh; Alexey V Glukhov; Zhan Gao; B Julie He; Elizabeth D Luczak; Mei-ling A Joiner; William Kutschke; Jinying Yang; J Kevin Donahue; Robert M Weiss; Isabella M Grumbach; Masahiro Ogawa; Peng-Sheng Chen; Igor Efimov; Dobromir Dobrev; Peter J Mohler; Thomas J Hund; Mark E Anderson
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

10.  The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model.

Authors:  E J Su; M Geyer; M Wahl; K Mann; D Ginsburg; H Brohmann; K U Petersen; D A Lawrence
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

View more
  21 in total

1.  Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis.

Authors:  Sanjana Dayal; Sean X Gu; Ryan D Hutchins; Katina M Wilson; Yi Wang; Xiaoyun Fu; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-11       Impact factor: 8.311

2.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

Review 3.  Regulated methionine oxidation by monooxygenases.

Authors:  Bruno Manta; Vadim N Gladyshev
Journal:  Free Radic Biol Med       Date:  2017-02-14       Impact factor: 7.376

Review 4.  Utility of microfluidic devices to study the platelet-endothelium interface.

Authors:  Jevgenia Zilberman-Rudenko; Joanna L Sylman; Kathleen S Garland; Cristina Puy; Andrew D Wong; Peter C Searson; Owen J T McCarty
Journal:  Platelets       Date:  2017-03-30       Impact factor: 3.862

5.  Protein methionine oxidation augments reperfusion injury in acute ischemic stroke.

Authors:  Sean X Gu; Ilya O Blokhin; Katina M Wilson; Nirav Dhanesha; Prakash Doddapattar; Isabella M Grumbach; Anil K Chauhan; Steven R Lentz
Journal:  JCI Insight       Date:  2016-05-19

6.  Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.

Authors:  Paula J Klutho; Steven M Pennington; Jason A Scott; Katina M Wilson; Sean X Gu; Prakash Doddapattar; Litao Xie; Ashlee N Venema; Linda J Zhu; Anil K Chauhan; Steven R Lentz; Isabella M Grumbach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-08       Impact factor: 8.311

7.  Sodium Reduction, Metabolomic Profiling, and Cardiovascular Disease Risk in Untreated Black Hypertensives.

Authors:  Li Chen; Feng J He; Yanbin Dong; Ying Huang; Gregory A Harshfield; Haidong Zhu
Journal:  Hypertension       Date:  2019-05-13       Impact factor: 9.897

8.  Oxidation shuts down an auto-inhibitory mechanism of von Willebrand factor.

Authors:  Rachel Tsai; Gianluca Interlandi
Journal:  Proteins       Date:  2021-03-02

9.  Sulphur Atoms from Methionines Interacting with Aromatic Residues Are Less Prone to Oxidation.

Authors:  Juan C Aledo; Francisco R Cantón; Francisco J Veredas
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

Review 10.  Vascular smooth muscle contraction in hypertension.

Authors:  Rhian M Touyz; Rheure Alves-Lopes; Francisco J Rios; Livia L Camargo; Aikaterini Anagnostopoulou; Anders Arner; Augusto C Montezano
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.